Related Experiment Video

Updated: Jun 3, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Recent improvements in the Turkish Childhood National Immunization Program

Mehmet Ceyhan1

  • 1Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey.

The Turkish Journal of Pediatrics
|March 25, 2011
PubMed

Insights

Turkey's National Immunization Program (NIP) has significantly improved vaccine quality, coverage, and pathogen protection since 2002. Sustaining these gains requires ongoing political commitment and multi-sectoral collaboration for public health.

Area of Science:

  • Public Health
  • Immunization Policy
  • Pediatric Healthcare

Background:

  • The Childhood National Immunization Program (NIP) is vital for national health.
  • Turkey's NIP historically included basic vaccines like BCG, DPT, polio, and measles.
  • Vaccination significantly impacts overall public health status.

Purpose of the Study:

  • To analyze the evolution and impact of Turkey's National Immunization Program.
  • To assess improvements in vaccine quality, coverage, and pathogen inclusion.
  • To identify factors crucial for the sustainability of national immunization efforts.

Main Methods:

  • Review of governmental policy changes impacting the NIP.
  • Analysis of collaboration between the Ministry of Health and the Advisory Board of Immunization.
  • Comparative assessment of the Turkish NIP against European standards.

Main Results:

  • Turkey's NIP underwent significant improvements post-2002 due to policy shifts and expert collaboration.
  • The program now offers enhanced vaccine quality, higher vaccination rates, and broader pathogen coverage.
  • The current Turkish NIP is comparable to or exceeds other European countries' programs.

Conclusions:

  • Turkey's NIP has achieved a high standard, comparable to leading European nations.
  • Sustaining the program's success necessitates consistent prioritization within state health policies.
  • Continued political commitment, multi-sectoral collaboration, and public awareness are essential for long-term effectiveness.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.